Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Archive ouverte

Seror, Raphaele | Baron, Gabriel | Camus, Marine | Cornec, Divi | Perrodeau, Elodie | Bowman, Simon, J | Bombardieri, Michele | Bootsma, Hendrika | Gottenberg, Jacques-Eric | Fisher, Benjamin | Hueber, Wolfgang | van Roon, Joel, A | Devauchelle-Pensec, Valérie | Gergely, Peter | Mariette, Xavier | Porcher, Raphael

Edité par CCSD ; BMJ Publishing Group -

International audience. Objective To develop a composite responder index in primary Sjögren’s syndrome (pSS): the Sjögren’s Tool for Assessing Response (STAR). Methods To develop STAR, the NECESSITY (New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients) consortium used data-driven methods based on nine randomised controlled trials (RCTs) and consensus techniques involving 78 experts and 20 patients. Based on reanalysis of rituximab trials and the literature, the Delphi panel identified a core set of domains with their respective outcome measures. STAR options combining these domains were proposed to the panel for selection and improvement. For each STAR option, sensitivity to change was estimated by the C-index in nine RCTs. Delphi rounds were run for selecting STAR. For the options remaining before the final vote, a meta-analysis of the RCTs was performed. Results The Delphi panel identified five core domains (systemic activity, patient symptoms, lachrymal gland function, salivary gland function and biological parameters), and 227 STAR options combining these domains were selected to be tested for sensitivity to change. After two Delphi rounds, a meta-analysis of the 20 remaining options was performed. The candidate STAR was then selected by a final vote based on metrological properties and clinical relevance. Conclusion The candidate STAR is a composite responder index that includes all main disease features in a single tool and is designed for use as a primary endpoint in pSS RCTs. The rigorous and consensual development process ensures its face and content validity. The candidate STAR showed good sensitivity to change and will be prospectively validated by the NECESSITY consortium in a dedicated RCT.

Suggestions

Du même auteur

Examining the biological pathways underlying clinical heterogeneity in Sjogren’s syndrome: proteomic and network analysis

Archive ouverte | Berry, Joe Scott | CCSD

International audience. Objectives Stratification approaches are vital to address clinical heterogeneity in Sjogren’s syndrome (SS). We previously described that the Newcastle Sjogren’s Stratification Tool (NSST) id...

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

Archive ouverte | Tarn, Jessica | CCSD

International audience

Phenotype of biopsy-proven patients with primary Sjögren syndrome lacking ro autoantibodies: high frequency of dryness symptoms with low systemic activity (big data Sjögren projct).

Archive ouverte | Retamozo, Soledad | CCSD

International audience

Chargement des enrichissements...